It has been an interesting week for Ares Capital (ARCC) as the company posted a sharp decline in its stock price, dropping over 4% at a time when both the S&P 500 and Nasdaq posted gains. This pullback happened just days after Ares Capital announced the issuance of $650 million in 5.1% notes due 2031, signaling a significant move in its capital structure. The borrowing is intended to repay outstanding debt and leave room for future investments, but the combination of a new bond offering and a pessimistic earnings forecast seems to have unsettled some in the market. Looking at the bigger picture, Ares Capital has seen a steady climb over the past year, returning 15%, with an especially strong run when you zoom out to longer timeframes. The company has more than doubled investors' money over five years. Still, recent momentum has faded, with a nearly 6% loss over the past month and a smaller dip over the past three months. Short-term worries about lower earnings and declining revenue in the next quarter have put a cloud over what had been an extended period of outperformance. So after this recent drop, is Ares Capital trading at a discount worth considering or is the market simply reflecting concerns about slowing growth prospects?

Price-to-Earnings of 11x: Is it justified?

Ares Capital is currently valued at a price-to-earnings (P/E) ratio of 11 times, which is markedly lower than the US Capital Markets industry average of 27.1x. This significant discount suggests the stock is undervalued when compared to peers in its sector.

The price-to-earnings ratio measures how much investors are willing to pay today for a dollar of the company's earnings. In capital markets, this ratio is a key benchmark that helps investors assess whether a stock is priced attractively relative to its profitability.

A lower P/E could point to skepticism over future growth. For long-term holders, this figure might represent an opportunity if Ares Capital's earnings quality and consistent profits hold up as forecasted.

Result: Fair Value of $21.16 (UNDERVALUED)

See our latest analysis for Ares Capital.

However, slower revenue and net income growth could pose challenges for Ares Capital if market conditions worsen or investor sentiment shifts more negatively.

Find out about the key risks to this Ares Capital narrative.

Another View: What Does Our DCF Model Say?

Taking a step back from market comparisons, our DCF model offers a different perspective. Instead of focusing on recent earnings, it estimates value based on the company’s projected future cash flows. This approach suggests a result that does not align with the one given by earnings multiples. Does this discrepancy challenge the idea of a clear bargain, or does it simply add nuance?

Look into how the SWS DCF model arrives at its fair value.

Stay updated when valuation signals shift by adding Ares Capital to your watchlist or portfolio. Alternatively, explore our screener to discover other companies that fit your criteria.

Build Your Own Ares Capital Narrative

If you have a different perspective or would rather dive into the numbers yourself, you can easily craft your own narrative in just a few minutes. Do it your way

A great starting point for your Ares Capital research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Don’t limit your opportunities. The Simply Wall Street Screener makes it easy to uncover stocks that fit your strategy. Take action now and find your next potential winner before the crowd does.

• Target stable income by checking out top companies paying generous yields over 3% through our handpicked selection of dividend stocks with yields > 3%.
• Unlock value plays trading below their intrinsic worth and see which stocks stand out as true bargains with our undervalued stocks based on cash flows.
• Tap into future healthcare breakthroughs by scanning innovative firms at the intersection of medicine and artificial intelligence using our healthcare AI stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.